MANIA
Clinical trials for MANIA explained in plain language.
Never miss a new study
Get alerted when new MANIA trials appear
Sign up with your email to follow new studies for MANIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Abilify for kids: early safety trial shows promise
Disease control CompletedThis study tested the safety and tolerability of aripiprazole (Abilify) in 21 children and adolescents aged 10 to 17 with schizophrenia or mania. Participants took daily doses of 2 to 30 mg for 14 days. The main goals were to see how many could tolerate the highest dose without s…
Matched conditions: MANIA
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can meal timing and blue glasses tame mania? new pilot study explores Drug-Free options
Symptom relief CompletedThis pilot study tested whether time-restricted eating and blue-blocking glasses can help people with bipolar disorder during manic episodes. The goal was to see if these simple, drug-free approaches are feasible and safe for inpatients. Twenty-one participants were enrolled to t…
Matched conditions: MANIA
Phase: NA • Sponsor: Ottawa Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New study sheds light on antipsychotic safety during pregnancy and breastfeeding
Knowledge-focused CompletedThis completed observational study followed 168 pregnant or breastfeeding women with schizophrenia, psychosis, or mania who were already taking long-acting injectable antipsychotics. Researchers measured drug levels in the mother's blood, breastmilk, and the baby's blood to under…
Matched conditions: MANIA
Sponsor: University of Liverpool • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC